Heat Biologics (NASDAQ: HTBX) announced that it has enrolled the first patient in a Phase 1b clinical trial investigating the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE